These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 31888532)

  • 1. TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.
    Jiang Y; Zhang J; Zhao J; Li Z; Chen H; Qiao Y; Chen X; Liu K; Dong Z
    BMC Cancer; 2019 Dec; 19(1):1264. PubMed ID: 31888532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity.
    Gao S; Li S; Duan X; Gu Z; Ma Z; Yuan X; Feng X; Wang H
    Mol Carcinog; 2017 Oct; 56(10):2301-2316. PubMed ID: 28574599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
    Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
    Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis.
    Li Z; Qin X; Bian W; Li Y; Shan B; Yao Z; Li S
    J Exp Clin Cancer Res; 2019 Nov; 38(1):477. PubMed ID: 31775815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine Leukemia Inhibitory Factor Promotes Esophageal Squamous Cell Carcinoma Progression via Src Family Kinase-Dependent Yes-Associated Protein Activation.
    Kawazoe T; Saeki H; Oki E; Oda Y; Maehara Y; Mori M; Taniguchi K
    Mol Cancer Res; 2020 Dec; 18(12):1876-1888. PubMed ID: 33004621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
    Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
    J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA polymerase iota (Pol ι) promotes invasion and metastasis of esophageal squamous cell carcinoma.
    Zou S; Shang ZF; Liu B; Zhang S; Wu J; Huang M; Ding WQ; Zhou J
    Oncotarget; 2016 May; 7(22):32274-85. PubMed ID: 27057634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer.
    Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATAD2 interacts with C/EBPβ to promote esophageal squamous cell carcinoma metastasis via TGF-β1/Smad3 signaling.
    Cao LJ; Zhang YJ; Dong SQ; Li XZ; Tong XT; Chen D; Wu ZY; Zheng XH; Xue WQ; Jia WH; Zhang JB
    J Exp Clin Cancer Res; 2021 Mar; 40(1):109. PubMed ID: 33757572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling.
    Hu X; Wu D; He X; Zhao H; He Z; Lin J; Wang K; Wang W; Pan Z; Lin H; Wang M
    Mol Cancer; 2019 Nov; 18(1):160. PubMed ID: 31722716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
    Bolidong D; Domoto T; Uehara M; Sabit H; Okumura T; Endo Y; Nakada M; Ninomiya I; Miyashita T; Wong RW; Minamoto T
    Sci Rep; 2020 Jul; 10(1):11807. PubMed ID: 32678196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
    Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3β.
    Liu RM; Sun DN; Jiao YL; Wang P; Zhang J; Wang M; Ma J; Sun M; Gu BL; Chen P; Liu K; Ma H; Gao SG; Ma YF; Qi YJ
    Cancer Lett; 2018 Jan; 412():289-296. PubMed ID: 29079416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.
    Ma S; Lu CC; Yang LY; Wang JJ; Wang BS; Cai HQ; Hao JJ; Xu X; Cai Y; Zhang Y; Wang MR
    J Exp Clin Cancer Res; 2018 Aug; 37(1):183. PubMed ID: 30081903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL6 fuels the growth and metastases of esophageal squamous cell carcinoma cells both in vitro and in vivo through upregulation of PD-L1 via activation of STAT3 pathway.
    Zheng S; Shen T; Liu Q; Liu T; Tuerxun A; Zhang Q; Yang L; Han X; Lu X
    J Cell Physiol; 2021 Jul; 236(7):5373-5386. PubMed ID: 33368292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.
    Cheng X; Wei L; Huang X; Zheng J; Shao M; Feng T; Li J; Han Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Jun; 152(8):1985-1997.e12. PubMed ID: 28209530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression.
    Du X; Xu Q; Pan D; Xu D; Niu B; Hong W; Zhang R; Li X; Chen S
    Cell Death Dis; 2019 Nov; 10(12):873. PubMed ID: 31740661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma.
    Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Anticancer Res; 2016 Dec; 36(12):6457-6466. PubMed ID: 27919968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting p21-activated kinase 1 inhibits growth and metastasis via Raf1/MEK1/ERK signaling in esophageal squamous cell carcinoma cells.
    Chen L; Bi S; Hou J; Zhao Z; Wang C; Xie S
    Cell Commun Signal; 2019 Apr; 17(1):31. PubMed ID: 30971268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.